🇺🇸 FDA
Pipeline program

Tianqi Pingchan Granule

XHEC-C-2019-033-2

Unknown small_molecule active

Quick answer

Tianqi Pingchan Granule for Levodopa-Induced Dyskinesia is a Unknown program (small_molecule) at Xinhua Hospital, Shanghai Jiao Tong University School of Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Indication
Levodopa-Induced Dyskinesia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials